Q: What makes Galen extraordinary?
A: We care. Our people are deeply commited to what we as a business are trying to achieve, and also facilitate our partners in achieving their visions too. With a mix of different backgrounds and diverse experience across the team, our people bring their unique perspectives and passion to everything we do.
Q: What do you feel is the biggest strength of the company right now?
A: Our resilience. We have a 'never give up' attitude and continue to adapt to the ever-changing market and landscape.
Q: What motivates you to achieve Galen's vision?
A: Knowing that we are creating something that will have a positive and lasting impact on peoples lives and carry on Galen's legacy.
Q: What do you think is the next big trend in the field?
A: Sustainability and building a greener pharmaceutical industry. This is something which is front of mind as we develop new products and add to our portfolio. Galen's vision is to benefit the health of all generations and key to this is the overall health of our planet.
Q: What do you see are the biggest challenges facing the industry?
A: It is an ever changing landscape with new drugs being developed and regulatory approvals becoming stricter. For operations, the scarcity of active pharmaceutical ingredients for basic drugs is the most challenging and so as a team we are continually working to mitigate any supply chain problems for our patients and customers.
Q: What are your immediate objectives?
A: Our expansion plans into Northern Europe is a key focus, as well as our organic growth through R&D projects and new product development coming this year.